期刊
JOURNAL OF IMMUNOLOGICAL METHODS
卷 278, 期 1-2, 页码 179-190出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0022-1759(03)00189-3
关键词
neurofilament; NfH; nomenclature; ELISA; CSF; neurodegeneration; axonal injury; SMI34; SMI35; SMI310; SMI32; SMI33; SMI37; SMI38; SMI311; NE14
Neurofilaments (Nf) are the major constitutents of the axoskeleton and body fluid Nf levels are an important tool for estimating axonal degeneration in vivo. This paper presents a new sandwich ELISA allowing quantification of the NfH(SM135) phosphoform from CSF, brain tissue and cell culture homogenates. The sensitivity of the NfH(SM135) ELISA is 0.2 ng/ml with a recovery of 119% and a mean within- and between-batch precision of 10.6% and 23%, respectively. CSF NfH(SM135) was stable at 4 degreesC, is not influenced by freeze-thaw cycles, and proteolysis present at room temperature could be prevented by adding protease inhibitors. Aggregate formation was observed for HPLC-purified bovine NfH and could be resolved by sonication. The upper reference value for CSF NfH(SM135) levels (0.73 ng/ml) was defined as the 95% cumulative frequency from 416 CSF samples. Based on this cutoff, a significantly higher proportion of patients with amyotrophic lateral sclerosis, space occupying lesions, disc prolapse and subarachnoid haemorrhage had pathologically elevated NfH(SM135) levels compared to patients with cluster headache or demyelinating disease. A new nomenclature is proposed to facilitate the comparison between ELISA, immunoblotting and immunocytochemistry. (C) 2003 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据